Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190939 · ClinicalTrials.gov registry record · NA
The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy
A NA study, sponsored by WellSpan Health.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
NCT05190939: Completed NA study, sponsored by WellSpan Health.
NCT05190939 is a NA study that has completed, run by WellSpan Health. The registered enrollment target is 276 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05190939, a NA study, has completed, sponsored by WellSpan Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
Study Summary
An investigation comparing the reliability of dye-aided versus dye-less evaluation of urinary tract integrity during intra-operative cystoscopy among patients undergoing hysterectomy.
Primary Outcome
Observers visually assess ureters on-screen simultaneously and independently. Ureteral jet efflux from each ureter is assigned a score on a linear visual scale from 0 to 5. The best of three scores of three consecutive jets from each ureter is assigned as the strength of ureteral jet. On a continuous visual scale, absent efflux is assigned as zero, slow or impaired efflux is assigned up to a score of 2, average flow neither sluggish nor brisk is assigned at least 2, and brisk flow is assigned a
Interventions
- DIAGNOSTIC_TEST No intervention
- DIAGNOSTIC_TEST water as bladder distending media
- DIAGNOSTIC_TEST intravenous dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2019-12-29 |
| Phase | NA |
What the finished NCT05190939 record still lists
NCT05190939 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which No intervention is the first listed.
NCT05190939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05190939 about?
NCT05190939 is a clinical study titled "The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy". An investigation comparing the reliability of dye-aided versus dye-less evaluation of urinary tract integrity during intra-operative cystoscopy among patients undergoing hysterectomy.
What is the current status of trial NCT05190939?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2018-07-01. Estimated completion is 2019-12-29.
What interventions are being tested in trial NCT05190939?
The interventions under investigation include: No intervention (DIAGNOSTIC_TEST), water as bladder distending media (DIAGNOSTIC_TEST), intravenous dye (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05190939?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05190939's enrollment target sits among peer trials
276 383rd of 2000 higher than 1,618 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI